The Perinatal Stem Cell Society was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped potential for use in medicine. For this reason, the society hosts an annual event known as the Perinatal Stem Cell Society Congress. It includes a scientific program with topics covering all aspects of the perinatal stem cell field, with attendees advancing perinatal stem cell research and focused on paths towards treatment.
Without question, perinatal stem cells represent one of the most promising areas of stem cell research. While perinatal stem cells are largely recognized for their therapeutic potential, these cells will also shape the fields of drug discovery and toxicology.
For this reason, I am honored to share an interview below with Kyle Cetrulo, President and Founder of the Perinatal Stem Cell Society. [Read more…]
FREEHOLD, NJ
TOKYO
FUJIFILM Corporation and Takeda Pharmaceutical have announced they will partner to develop regenerative therapies using iPS cell-derived cardiomyocytes produced by Fujfilm’s subsidiary, Cellular Dynamics International (CDI).
“We are delighted to initiate this partnership applying practical use of our iPSC-derived cardiac cells with Takeda, which has abundant experience in drug development and clinical trials. In addition to establishing new treatment methods for patients with heart disease, Fujifilm and Takeda will contribute to the elevation of regenerative medication business to the industrial stage by applying our engineering technologies to manufacture high-quality cells safely and efficiently.”